• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Model Number 385100
Device Problem Delivered as Unsterile Product (1421)
Patient Problem No Patient Involvement (2645)
Event Date 05/14/2020
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
 
Event Description
It was reported that hair-like foreign matter was found in the packaging of the bd q-syte¿ luer access split-septum stand-alone device before it was opened.The following information was provided by the initial reporter, translated from (b)(6) to english: "the clinical client reported to the armory department that before the package of q-syte was opened, there was the foreign matter which was suspected hair in the package".
 
Manufacturer Narrative
H.6.Investigation: a device history record review was performed for provided lot number 9031813 and the review did not reveal any detected quality issues during the production process that could have contributed to this incident.To aid in the investigation of this issue, two picture samples were received for evaluation by our quality engineer team.Through examination of the picture samples, a hair was observed within the unopened product packaging.Our quality team inspected the production process with the intention of identifying a possible cause for this incident; however, no abnormalities related to the production equipment, the employee gowning requirements, or the cleaning process were detected.It has been determined that this incident resulted from improper detection of faulty product during the inspection process.Based on the current cleaning procedures and 100% inspection plan, we believe this issue has a low chance of recurrence.In response to this incident, a notification was sent to the manufacturing personnel to increase the focus on the segregation of defective product.
 
Event Description
It was reported that hair-like foreign matter was found in the packaging of the bd q-syte¿ luer access split-septum stand-alone device before it was opened.The following information was provided by the initial reporter, translated from chinese to english: "the clinical client reported to the armory department that before the package of q-syte was opened, there was the foreign matter which was suspected hair in the package".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE LUER ACCESS SPLIT-SEPTUM STAND-ALONE DEVICE
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
MDR Report Key10114463
MDR Text Key195432004
Report Number9610847-2020-00167
Device Sequence Number1
Product Code FPA
UDI-Device Identifier30382903851004
UDI-Public30382903851004
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date11/30/2023
Device Model Number385100
Device Catalogue Number385100
Device Lot Number9031813
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/14/2020
Initial Date FDA Received06/03/2020
Supplement Dates Manufacturer Received05/14/2020
Supplement Dates FDA Received06/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-